CapitalStars Research Update News
RBI releases restructuring norms for NBFCs
As per RBIs norms revisions of the date of DCCO and consequential shift in repayment schedule for equal or shorter duration will not be treated as restructuring subject to certain conditions.
Sun Pharma to seek USFDA approval for 2-3 innovative products
Sun Pharma is hinted that it is close to fling approvals for three New Chemical Entities (NCE) or innovative products developed by its subsidiary SPARC and are in final stages of clinical trials.
Thomas Cook India acquires Sri Lanka-based Luxe Asia
The acquisition of Luxe Asia reiterates delivery of our strategic intent of establishing a global destination management presence. Luxe Asia will continue to focus on its core domain of inbound tourism across key global source markets.
M&M rallies on plans to launch ‘TUV3OO’ in September
Shares of Mahindra & Mahindra (M&M) gained over 3% to Rs1364 on NSE on back of plans to launch its compact SUV ‘ TUV3OO’ in September; positive for the company Utility Vehicle segment market leader M&M unveiled its plans to launch a compact sports utility vehicle (SUV) later in the year.
CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market. CapitalStars also aveliable on social network
CapitalStars is a research house and an investment advisory company carrying out operations in the Indian Equities and commodity market. We generate intraday as well as delivery calls in Stock cash and F&O in NSE & BSE, Commodities including bullions, metals & Agro- commodities traded in MCX and NCDEX.
www.capitalstars.com | T:+91-731-6790000,6669900
CapitalStars Financial Research Financial Advisory Services
